title: The evolving role of CETP inhibition: beyond HDL cholesterol.
authors.affiliation: Department of Primary Care and Public Health, School of Public Health, Imperial College London, London W6 8RP, UK. Electronic address: k.ray@imperial.ac.uk.
authors.forename: Kausik K
authors.initials: KK
authors.lastname: Ray
authors.affiliation: Cardiovascular Sciences, Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK.
authors.forename: Antonio J
authors.initials: AJ
authors.lastname: Vallejo-Vaz
mesh_terms: D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage*; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage*; D011758:Pyrroles / Q000008:administration & dosage*; D011804:Quinolines / Q000494:pharmacology*; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D053480:Cholesterol Ester Transfer Proteins; D005464:Fluorobenzenes; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D011804:Quinolines; D013449:Sulfonamides